Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2016 3
2017 2
2018 1
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
AP-2γ Is Required for Maintenance of Multipotent Mammary Stem Cells.
Gu VW, Cho E, Thompson DT, Cassady VC, Borcherding N, Koch KE, Wu VT, Lorenzen AW, van der Heide DM, White JR, Kulak MV, Williams T, Zhang W, Weigel RJ. Gu VW, et al. Among authors: lorenzen aw. Stem Cell Reports. 2021 Jan 12;16(1):106-119. doi: 10.1016/j.stemcr.2020.12.002. Epub 2020 Dec 30. Stem Cell Reports. 2021. PMID: 33382976 Free PMC article.
Intraoperative Radiotherapy for Breast Cancer Treatment in a Rural Community.
Lorenzen AW, Kiriazov B, De Andrade JP, Lizarraga IM, Scott-Conner CE, Sugg SL, Erdahl LM, Sun W, Weigel RJ. Lorenzen AW, et al. Ann Surg Oncol. 2018 Oct;25(10):3004-3010. doi: 10.1245/s10434-018-6574-7. Epub 2018 Jul 20. Ann Surg Oncol. 2018. PMID: 30030731 Free PMC article.
EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.
De Andrade JP, Park JM, Gu VW, Woodfield GW, Kulak MV, Lorenzen AW, Wu VT, Van Dorin SE, Spanheimer PM, Weigel RJ. De Andrade JP, et al. Among authors: lorenzen aw. Mol Cancer Ther. 2016 Mar;15(3):503-11. doi: 10.1158/1535-7163.MCT-15-0548-T. Epub 2016 Feb 1. Mol Cancer Ther. 2016. PMID: 26832794 Free PMC article.
Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer.
De Andrade JP, Lorenzen AW, Wu VT, Bogachek MV, Park JM, Gu VW, Sevenich CM, Cassady VC, Beck AC, Kulak MV, Robinson RA, Lal G, Weigel RJ. De Andrade JP, et al. Among authors: lorenzen aw. Oncotarget. 2017 Oct 23;8(70):114801-114815. doi: 10.18632/oncotarget.21954. eCollection 2017 Dec 29. Oncotarget. 2017. PMID: 29383121 Free PMC article.